PubMed:10342656 / 568-790 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/10342656","sourcedb":"PubMed","sourceid":"10342656","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/10342656","text":"Judging from our experience and the reviewed literature, the addition of prophylactic anti-anaerobe drugs should be strongly considered until an optimal prophylactic regimen will be defined by randomized controlled trials.","tracks":[{"project":"Inflammaging","denotations":[{"id":"T5","span":{"begin":0,"end":222},"obj":"Sentence"},{"id":"T5","span":{"begin":0,"end":222},"obj":"Sentence"}],"attributes":[{"subj":"T5","pred":"source","obj":"Inflammaging"},{"subj":"T5","pred":"source","obj":"Inflammaging"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"Inflammaging","color":"#93ecb8","default":true}]}]}}